Travere Therapeutics
Travere Therapeutics is seeking a Vice President, Regulatory Strategy Diligence to lead the Regulatory Due Diligence team, assessing clinical and commercial-stage assets for external business development opportunities. The role involves evaluating potential licensing, acquisition, and partnership opportunities, identifying material technical risks, and providing strategic recommendations to support transaction decisions and post-deal integration. This position requires deep regulatory development expertise across various therapeutic modalities and strong collaboration with cross-functional leaders.
Headquarters
San Diego, California, United States
Company Size
201-500 employees
Founded
2020
Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life-changing therapies to people living with rare disease.
How Investors Are Reacting To Travere Therapeutics (TVTX) FILSPARI Momentum And Mirum Milestone Windfall
1 day ago
Piper Sandler Increases Target Price for Travere Therapeutics (TVTX)
3 days ago
Travere Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
3 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Travere Therapeutics.
163% above the average for this role
Travere Therapeutics, Inc. (TVTX): A Bull Case Theory
2 weeks ago
Senior Director, Development Sciences Licensing & Acquisitions
AbbVie
Manager, Regulatory Affairs - Biomaterials
Johnson & Johnson
Business Development Lead
Roche
Exec Director, PDM Due Diligence Leader
Gilead Sciences
Senior Director, Global Regulatory Strategy
AstraZeneca
Senior Manager, Business Development
Tris Pharma